Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma

骨肉瘤 医学 免疫组织化学 化疗 坏死 活检 内科学 疾病 肿瘤科 病理
作者
Elham Nasri,Dianne Torrence,Terrie Vasilopoulos,Jacquelyn A. Knapik,Joanne Lagmay,John D. Reith,Charles P. Gibbs
出处
期刊:The cancer journal [Lippincott Williams & Wilkins]
卷期号:30 (3): 133-139 被引量:2
标识
DOI:10.1097/ppo.0000000000000714
摘要

Osteosarcoma is the most common primary malignant neoplasm of bone. Despite recent advances in the management of the disease, the overall survival of patients has failed to improve in the past 30 years due to the biological and genetic complexities of the disease and the lack of reliable prognostic and predictive markers to guide the treatments. Histologic tumor necrosis in response to chemotherapy has served as the most reliable predictor of disease outcome for years. Patients with a good histologic response (greater than 90% tumor necrosis) to chemotherapy had better disease outcomes compared with patients with a poor histologic response (less than 90% tumor necrosis). With the changes in the intensity of chemotherapeutic regimens, the prognostic value of histologic measurement of tumor necrosis has been questioned in recent studies. Purpose In this study, we used a series of immunohistochemical measurements of 2 cell cycle regulators, p16 and p21, to evaluate their prognostic value, separately and in combination, for the disease outcomes. Method A total of 101 patients with high-grade osteosarcoma were included in this study. Clinicopathologic data were collected, and immunohistochemistry for p16 and p21 was performed and interpreted by 3 independent pathologists. Statistical analysis was performed to assess the strength of each of these markers relative to disease outcome. Results Our results indicate that more than 90% expression (high) of p16 by immunohistochemistry on the initial biopsy has a strong predictive value for good histologic response to chemotherapy. The patients are also more likely to survive the past 5 years and less likely to develop metastasis than patients with less than 90% p16 (low) expression. The results for p21, on the other hand, show a unique pattern of relationship to the clinicopathologic outcomes of the disease. Patients with less than 1% (low) or more than 50% (high) expression of p21 by immunohistochemistry show a higher chance of metastasis, poor necrotic response to chemotherapy, and an overall decreased survival rate when compared with p21 expression between 1% and 50% (moderate). Our results also showed that the expression of p16 and combined p16 and p21 demonstrates a stronger predictive relationship to 5-year survival than tumor histologic necrosis and p21 alone. Discussion The results of this study, once proven to be reproducible by a larger number of patients, will be valuable in the initial assessment and risk stratification of the patients for treatment and possibly the clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Firsterchao的应助被lufang采纳,获得10
1秒前
蜗牛完成签到,获得积分10
1秒前
violet完成签到,获得积分10
1秒前
柔弱的冰兰完成签到,获得积分20
2秒前
李健的应助被顺利的莺采纳,获得10
2秒前
YOUNG929的应助被快乐友儿采纳,获得10
3秒前
3秒前
Mr先生完成签到 ,获得积分10
3秒前
shelemi发布了新的文献求助10
3秒前
平淡荟完成签到,获得积分10
3秒前
洛神之心1124完成签到,获得积分10
3秒前
萤熵完成签到,获得积分10
3秒前
果酱的奥特曼完成签到,获得积分10
4秒前
张张完成签到,获得积分10
4秒前
glowe完成签到,获得积分10
4秒前
乐乐关注了科研通微信公众号
4秒前
东山小红完成签到,获得积分10
4秒前
沉静野狼完成签到,获得积分10
5秒前
橘子完成签到,获得积分10
5秒前
十一点睡觉完成签到,获得积分10
5秒前
5秒前
yyyyy完成签到,获得积分10
5秒前
6秒前
忧伤的静竹完成签到,获得积分10
7秒前
洛宁发布了新的文献求助10
7秒前
NiNi完成签到,获得积分10
7秒前
竞鹤完成签到,获得积分10
7秒前
7秒前
周末完成签到,获得积分10
7秒前
SciGPT的应助被奋斗世德采纳,获得10
7秒前
七安完成签到 ,获得积分10
8秒前
sssane发布了新的文献求助10
8秒前
科研通AI6.4的应助被呼呼哈哈采纳,获得10
8秒前
李爱国的应助被本末倒纸采纳,获得10
8秒前
9秒前
lufang完成签到,获得积分10
9秒前
ldy完成签到,获得积分10
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162